rs782517934
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_005629.4(SLC6A8):āc.975A>Cā(p.Thr325=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000612 in 1,209,647 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.000036 ( 0 hom., 1 hem., cov: 24)
Exomes š: 0.000064 ( 0 hom. 23 hem. )
Consequence
SLC6A8
NM_005629.4 synonymous
NM_005629.4 synonymous
Scores
5
Clinical Significance
Conservation
PhyloP100: -5.49
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_addAF=-0.656634).
BP6
Variant X-153693325-A-C is Benign according to our data. Variant chrX-153693325-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 416006.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAdExome4 at 23 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A8 | NM_005629.4 | c.975A>C | p.Thr325= | synonymous_variant | 6/13 | ENST00000253122.10 | NP_005620.1 | |
SLC6A8 | NM_001142805.2 | c.975A>C | p.Thr325= | synonymous_variant | 6/13 | NP_001136277.1 | ||
SLC6A8 | NM_001142806.1 | c.630A>C | p.Thr210= | synonymous_variant | 6/13 | NP_001136278.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A8 | ENST00000253122.10 | c.975A>C | p.Thr325= | synonymous_variant | 6/13 | 1 | NM_005629.4 | ENSP00000253122 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000357 AC: 4AN: 112161Hom.: 0 Cov.: 24 AF XY: 0.0000291 AC XY: 1AN XY: 34359
GnomAD3 genomes
AF:
AC:
4
AN:
112161
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34359
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000131 AC: 24AN: 182997Hom.: 0 AF XY: 0.000118 AC XY: 8AN XY: 67789
GnomAD3 exomes
AF:
AC:
24
AN:
182997
Hom.:
AF XY:
AC XY:
8
AN XY:
67789
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000638 AC: 70AN: 1097433Hom.: 0 Cov.: 32 AF XY: 0.0000634 AC XY: 23AN XY: 362831
GnomAD4 exome
AF:
AC:
70
AN:
1097433
Hom.:
Cov.:
32
AF XY:
AC XY:
23
AN XY:
362831
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000356 AC: 4AN: 112214Hom.: 0 Cov.: 24 AF XY: 0.0000291 AC XY: 1AN XY: 34422
GnomAD4 genome
AF:
AC:
4
AN:
112214
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34422
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
17
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 05, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2023 | SLC6A8: BP4, BP7, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 14, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Creatine transporter deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
D;D
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at